CAC
PFE icon

Cowen and Company’s Pfizer PFE Stock Holding History

Cowen and Company’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-106,300
Closed -$4K – 706
2021
Q4 		$4K Buy
+106,300
New +$5.27M ﹤0.01% 607
2020
Q4 		– Sell
-15,810
Closed -$8K – 497
2020
Q3 		$8K Sell
15,810
-36,574
-70% -$1.28M ﹤0.01% 404
2020
Q2 		$4K Buy
+52,384
New +$1.78M ﹤0.01% 378

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Cowen and Company's PFE Position: Q1 2022 in Review

Cowen and Company sold out of Pfizer (PFE) in Q1 2022, closing a stake of 98,385 shares — an estimated $5.81M sold.

Cowen and Company first reported a position in PFE in Q3 2020 and held it in 2 quarters. The position peaked at $5.81M in Q4 2021. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

  • Cowen and Company reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
  • Cowen and Company sold 98,385 Pfizer shares in Q1 2022, an estimated $5.81M.
  • Cowen and Company first reported a position in Pfizer in Q3 2020 and held it in 2 quarters.
  • Cowen and Company's Pfizer position peaked at $5.81M in Q4 2021.
  • 3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on Cowen and Company's 13F filing for Q1 2022, filed 16 May 2022.